-
Media Room Article
Cancer Research Institute to Host Annual Virtual Immunotherapy Patient Summit on November 11-12, 2022
Moderated by Emmy award-winning TV host, Tamron Hall, the free 2-day online event connects thousands of patients… -
Media Room Article
Cancer Research Institute’s Spanish-Language Virtual Immunotherapy Patient Summit Now Available On Demand to Help Close the Information Gap for Hispanic Cancer Patients
The free event, moderated by Ana Patricia Gámez, shared the latest promising research by top immunotherapy experts,… -
Media Room Article
Cancer Research Institute to Honor Scientists for Groundbreaking Discoveries Leading to New Immune-Based Strategies that Target Gasdermins in Cancer Treatment
CRI to give the 2022 William B . Coley Award for Distinguished Research in Basic and Tumor… -
Media Room Article
Cancer Research Institute to Host Second Annual Spanish-Language Virtual Immunotherapy Patient Summit
The free online event will connect cancer patients and caregivers with the latest promising research findings shared… -
Media Room Article
Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today’s Visionaries in Cancer Immunotherapy Research
Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer… -
Media Room Article
Cellular Cancer Immunotherapy Development Evolves, Expands with New Technologies and Targets
Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends…
-
Media Room Article
Cancer Research Institute Hosts 10th Annual Cancer Immunotherapy Month™ Celebrating Lifesaving Discovery in Immuno-Oncology
Awareness and educational program offerings for cancer patients and caregivers about the latest advances in cancer immunotherapy…
-
Media Room Article
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian…
-
Media Room Article
Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points…
